i understand they had African experience no doubt about it which is why they were put there in the first place however, even they said they were out of their comfort zone because they had no experience in the lithium space hence they were trying to find a suitable MD with lithium experience. In addition, particularly with Gill Swaby you have to agree they were taking advantage of the company funds when her services were clearly redundant but still continued to drain funds. I never dealt with Greg, but James Mckay was the one I respected the most out of the bunch.
Chris leaving AJM from his responses (paraphrasing) he enjoys being development stages of the mining experience and wanted to make a name for himself (i.e. being CEO). I think thats understandable considering at the time BGS was probably one of few projects in the world to be at that stage.
- Forums
- ASX - By Stock
- FFX
- Re-Rating: General Lithium & Mali Lithium
Re-Rating: General Lithium & Mali Lithium, page-222
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online